No Picture
Trading Ideas

Billionaire investor Steve Cohen: 'After an earthquake there are tremors'

Billionaire trader Steven A. Cohen is cautioning the staff of his investment firm, Point72 Asset Management, to remain cautious amid markets that have recovered slightly from coronavirus-driven lows. Cohen also wrote that his $16 billion firm’s returns are “essentially flat for the year,” a result that “speaks to how well our investment professionals have managed risk in such a challenging environment.” Point72 is best known for stock market investments, its core hedge fund strategy, although it also bets on other securities following a so-called macro style, which involves global wagers on lots of asset classes at once …read more […]

Healthcare

CytoDyn (OTC: CYDY) Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

VANCOUVER, Washington, Mar 31, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]

Healthcare

FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

VANCOUVER, Washington, March 31, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the […]

No Picture
Trading Ideas

Judicial Ruling Guts Amarin (AMRN) Stock; What’s Next?

If after seeing Amarin (AMRN) stock tumble 35% over the past year, you consoled yourself with the knowledge that “at least it can’t get any worse” — surprise! It just got worse.On Monday, a judge for the United States District Court for the District of Nevada ruled against Amarin and in favor of two generic drug manufacturers seeking to produce drugs based on Amarin’s Vascepa hypertriglyceridemia treatment, invalidating six Amarin patents in the process. Of course, Amarin quickly promised to “vigorously pursue all available remedies, including an appeal of the Court’s decision and a preliminary injunction pending appeal to … …read more […]

No Picture
Trading Ideas

Marriott’s Latest Data Breach Impacts 5.2 Million Travelers

The world’s largest hotel company has another data breach on its hands. Marriott International notified about 5.2 million guests Tuesday that their information was compromised through an app used to provide services at hotels. From mid-January of this year through the end of February, “an unexpected amount of guest information” was accessed through two employees’ […] …read more […]